These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38519578)

  • 1. Elevated postoperative carcinoembryonic antigen guides adjuvant chemotherapy for stage II colon cancer: a multicentre cohort retrospective study.
    Pu H; Yang W; Liu M; Pang X; Chen Y; Xiong Q
    Sci Rep; 2024 Mar; 14(1):6889. PubMed ID: 38519578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome.
    Konishi T; Shimada Y; Hsu M; Tufts L; Jimenez-Rodriguez R; Cercek A; Yaeger R; Saltz L; Smith JJ; Nash GM; Guillem JG; Paty PB; Garcia-Aguilar J; Gonen M; Weiser MR
    JAMA Oncol; 2018 Mar; 4(3):309-315. PubMed ID: 29270608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of the carcinoembryonic antigen level in patients with stage III colon cancer after surgery and adjuvant chemotherapy.
    Udagawa S; Osumi H; Kozuki R; Ooki A; Wakatsuki T; Kurihara N; Mukai T; Yamaguchi T; Akiyoshi T; Fukunaga Y; Yamaguchi K; Shinozaki E
    Surg Today; 2024 Jul; 54(7):692-701. PubMed ID: 38103076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
    Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
    Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
    Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer.
    Wang R; Xu B; Sun M; Pang X; Wang X; Zhu J; Lian J; Lu H
    Eur J Surg Oncol; 2023 Dec; 49(12):107138. PubMed ID: 37925830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
    Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
    Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study.
    Liao L; Tang J; Hong Z; Jiang W; Li Y; Kong L; Han K; Hou Z; Zhang C; Zhou C; Zhang L; Sui Q; Xiao B; Mei W; Yu J; Yang W; Pan Z; Ding PR
    BMC Cancer; 2024 Feb; 24(1):164. PubMed ID: 38302968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy benefits on patients with elevated carcinoembryonic antigen in stage IIA colon cancer: a SEER-based analysis.
    Zhou H; Wang S; Cai Z; Qiu E; Chen Q; Rao X; Han S; Li Z
    Int J Colorectal Dis; 2022 Dec; 37(12):2481-2489. PubMed ID: 36334109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient elevation in serum carcinoembryonic antigen while on adjuvant chemotherapy for colon cancer: Is this of prognostic importance?
    Lawrence N; Hinder V; Murray M; Macapagal J; Thompson P; Sharples K; Findlay M
    Asia Pac J Clin Oncol; 2017 Apr; 13(2):e124-e131. PubMed ID: 26245738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The robust performance of carcinoembryonic antigen levels after adjuvant chemotherapy for the recurrence risk stratification in patients with colorectal cancer.
    Ozawa T; Matsuda K; Ishihara S; Fukushima Y; Shimada R; Hayama T; Nozawa K; Hashiguchi Y
    J Surg Oncol; 2021 Jul; 124(1):97-105. PubMed ID: 33848373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Prediction and Adjuvant Chemotherapy Based on Tumor Marker for Stage IB Lung Adenocarcinoma.
    Wang Y; Zheng D; Chen T; Zhang J; Yao F; Chen H
    Ann Thorac Surg; 2020 Mar; 109(3):927-937. PubMed ID: 31614135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer.
    Ogata Y; Murakami H; Sasatomi T; Ishibashi N; Mori S; Ushijima M; Akagi Y; Shirouzu K
    J Surg Oncol; 2009 Jan; 99(1):65-70. PubMed ID: 18942720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
    He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
    World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High postoperative carcinoembryonic antigen as an indicator of high-risk stage II colon cancer.
    Morimoto Y; Takahashi H; Arita A; Itakura H; Fujii M; Sekido Y; Hata T; Fujino S; Ogino T; Miyoshi N; Uemura M; Matsuda C; Yamamoto H; Mizushima T; Doki Y; Eguchi H
    Oncol Lett; 2022 May; 23(5):167. PubMed ID: 35414828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporation of CEA Improves Risk Stratification in Stage II Colon Cancer.
    Spindler BA; Bergquist JR; Thiels CA; Habermann EB; Kelley SR; Larson DW; Mathis KL
    J Gastrointest Surg; 2017 May; 21(5):770-777. PubMed ID: 28290141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC).
    Muley T; Rolny V; He Y; Wehnl B; Escherich A; Warth A; Stolp C; Schneider MA; Dienemann H; Meister M; Herth FJ; Dayyani F
    Lung Cancer; 2018 Jun; 120():46-53. PubMed ID: 29748014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].
    Qin Q; Yang L; Zhou AP; Sun YK; Song Y; DU F; Wang JW
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):212-6. PubMed ID: 23880003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.